Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain.
The Food and Drug Administration has posted its review of Eli Lilly and Co.'s application to market the drug for a range of pain ailments, including lower back pain. FDA reviewers have questions about the statistical methods used to study the drug and liver side effects.
via abcnews.go.com
No comments:
Post a Comment